Global Multiple Sclerosis Drugs Market Professional Survey Report 2017

Publisher Name :
Date: 01-Nov-2017
No. of pages: 105
Inquire Before Buying

This report studies Multiple Sclerosis Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

- Biogen

- Teva Pharmaceutical

- Merck KGaA

- Novartis

- Bayer

- Sanofi

- Acorda Therapeutics

- Questcor Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Oral

- Injectable

- Intravenous

By Application, the market can be split into

- Hospital Pharmacy

- Retail Pharmacy

- Online Pharmacy

By Regions, this report covers (we can add the regions/countries as you want)

- North America

- China

- Europe

- Southeast Asia

- Japan

- India

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Multiple Sclerosis Drugs Market Professional Survey Report 2017

Table of Contents
Global Multiple Sclerosis Drugs Market Professional Survey Report 2017
1 Industry Overview of Multiple Sclerosis Drugs
1.1 Definition and Specifications of Multiple Sclerosis Drugs
1.1.1 Definition of Multiple Sclerosis Drugs
1.1.2 Specifications of Multiple Sclerosis Drugs
1.2 Classification of Multiple Sclerosis Drugs
1.2.1 Oral
1.2.2 Injectable
1.2.3 Intravenous
1.3 Applications of Multiple Sclerosis Drugs
1.3.1 Hospital Pharmacy
1.3.2 Retail Pharmacy
1.3.3 Online Pharmacy
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Multiple Sclerosis Drugs
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Multiple Sclerosis Drugs
2.3 Manufacturing Process Analysis of Multiple Sclerosis Drugs
2.4 Industry Chain Structure of Multiple Sclerosis Drugs
3 Technical Data and Manufacturing Plants Analysis of Multiple Sclerosis Drugs
3.1 Capacity and Commercial Production Date of Global Multiple Sclerosis Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Multiple Sclerosis Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Multiple Sclerosis Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Multiple Sclerosis Drugs Major Manufacturers in 2016
4 Global Multiple Sclerosis Drugs Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Multiple Sclerosis Drugs Capacity and Growth Rate Analysis
4.2.2 2016 Multiple Sclerosis Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Multiple Sclerosis Drugs Sales and Growth Rate Analysis
4.3.2 2016 Multiple Sclerosis Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Multiple Sclerosis Drugs Sales Price
4.4.2 2016 Multiple Sclerosis Drugs Sales Price Analysis (Company Segment)
5 Multiple Sclerosis Drugs Regional Market Analysis
5.1 North America Multiple Sclerosis Drugs Market Analysis
5.1.1 North America Multiple Sclerosis Drugs Market Overview
5.1.2 North America 2012-2017E Multiple Sclerosis Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Multiple Sclerosis Drugs Sales Price Analysis
5.1.4 North America 2016 Multiple Sclerosis Drugs Market Share Analysis
5.2 China Multiple Sclerosis Drugs Market Analysis
5.2.1 China Multiple Sclerosis Drugs Market Overview
5.2.2 China 2012-2017E Multiple Sclerosis Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Multiple Sclerosis Drugs Sales Price Analysis
5.2.4 China 2016 Multiple Sclerosis Drugs Market Share Analysis
5.3 Europe Multiple Sclerosis Drugs Market Analysis
5.3.1 Europe Multiple Sclerosis Drugs Market Overview
5.3.2 Europe 2012-2017E Multiple Sclerosis Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Multiple Sclerosis Drugs Sales Price Analysis
5.3.4 Europe 2016 Multiple Sclerosis Drugs Market Share Analysis
5.4 Southeast Asia Multiple Sclerosis Drugs Market Analysis
5.4.1 Southeast Asia Multiple Sclerosis Drugs Market Overview
5.4.2 Southeast Asia 2012-2017E Multiple Sclerosis Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Multiple Sclerosis Drugs Sales Price Analysis
5.4.4 Southeast Asia 2016 Multiple Sclerosis Drugs Market Share Analysis
5.5 Japan Multiple Sclerosis Drugs Market Analysis
5.5.1 Japan Multiple Sclerosis Drugs Market Overview
5.5.2 Japan 2012-2017E Multiple Sclerosis Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Multiple Sclerosis Drugs Sales Price Analysis
5.5.4 Japan 2016 Multiple Sclerosis Drugs Market Share Analysis
5.6 India Multiple Sclerosis Drugs Market Analysis
5.6.1 India Multiple Sclerosis Drugs Market Overview
5.6.2 India 2012-2017E Multiple Sclerosis Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Multiple Sclerosis Drugs Sales Price Analysis
5.6.4 India 2016 Multiple Sclerosis Drugs Market Share Analysis
6 Global 2012-2017E Multiple Sclerosis Drugs Segment Market Analysis (by Type)
6.1 Global 2012-2017E Multiple Sclerosis Drugs Sales by Type
6.2 Different Types of Multiple Sclerosis Drugs Product Interview Price Analysis
6.3 Different Types of Multiple Sclerosis Drugs Product Driving Factors Analysis
6.3.1 Oral of Multiple Sclerosis Drugs Growth Driving Factor Analysis
6.3.2 Injectable of Multiple Sclerosis Drugs Growth Driving Factor Analysis
6.3.3 Intravenous of Multiple Sclerosis Drugs Growth Driving Factor Analysis
7 Global 2012-2017E Multiple Sclerosis Drugs Segment Market Analysis (by Application)
7.1 Global 2012-2017E Multiple Sclerosis Drugs Consumption by Application
7.2 Different Application of Multiple Sclerosis Drugs Product Interview Price Analysis
7.3 Different Application of Multiple Sclerosis Drugs Product Driving Factors Analysis
7.3.1 Hospital Pharmacy of Multiple Sclerosis Drugs Growth Driving Factor Analysis
7.3.2 Retail Pharmacy of Multiple Sclerosis Drugs Growth Driving Factor Analysis
7.3.3 Online Pharmacy of Multiple Sclerosis Drugs Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Multiple Sclerosis Drugs
8.1 Biogen
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Biogen 2016 Multiple Sclerosis Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Biogen 2016 Multiple Sclerosis Drugs Business Region Distribution Analysis
8.2 Teva Pharmaceutical
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Teva Pharmaceutical 2016 Multiple Sclerosis Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Teva Pharmaceutical 2016 Multiple Sclerosis Drugs Business Region Distribution Analysis
8.3 Merck KGaA
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Merck KGaA 2016 Multiple Sclerosis Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Merck KGaA 2016 Multiple Sclerosis Drugs Business Region Distribution Analysis
8.4 Novartis
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Novartis 2016 Multiple Sclerosis Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Novartis 2016 Multiple Sclerosis Drugs Business Region Distribution Analysis
8.5 Bayer
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Bayer 2016 Multiple Sclerosis Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Bayer 2016 Multiple Sclerosis Drugs Business Region Distribution Analysis
8.6 Sanofi
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Sanofi 2016 Multiple Sclerosis Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Sanofi 2016 Multiple Sclerosis Drugs Business Region Distribution Analysis
8.7 Acorda Therapeutics
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Acorda Therapeutics 2016 Multiple Sclerosis Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Acorda Therapeutics 2016 Multiple Sclerosis Drugs Business Region Distribution Analysis
8.8 Questcor Pharmaceuticals
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Questcor Pharmaceuticals 2016 Multiple Sclerosis Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Questcor Pharmaceuticals 2016 Multiple Sclerosis Drugs Business Region Distribution Analysis
9 Development Trend of Analysis of Multiple Sclerosis Drugs Market
9.1 Global Multiple Sclerosis Drugs Market Trend Analysis
9.1.1 Global 2017-2022 Multiple Sclerosis Drugs Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Multiple Sclerosis Drugs Sales Price Forecast
9.2 Multiple Sclerosis Drugs Regional Market Trend
9.2.1 North America 2017-2022 Multiple Sclerosis Drugs Consumption Forecast
9.2.2 China 2017-2022 Multiple Sclerosis Drugs Consumption Forecast
9.2.3 Europe 2017-2022 Multiple Sclerosis Drugs Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Multiple Sclerosis Drugs Consumption Forecast
9.2.5 Japan 2017-2022 Multiple Sclerosis Drugs Consumption Forecast
9.2.6 India 2017-2022 Multiple Sclerosis Drugs Consumption Forecast
9.3 Multiple Sclerosis Drugs Market Trend (Product Type)
9.4 Multiple Sclerosis Drugs Market Trend (Application)
10 Multiple Sclerosis Drugs Marketing Type Analysis
10.1 Multiple Sclerosis Drugs Regional Marketing Type Analysis
10.2 Multiple Sclerosis Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Multiple Sclerosis Drugs by Region
10.4 Multiple Sclerosis Drugs Supply Chain Analysis
11 Consumers Analysis of Multiple Sclerosis Drugs
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Multiple Sclerosis Drugs Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Multiple Sclerosis Drugs
Table Product Specifications of Multiple Sclerosis Drugs
Table Classification of Multiple Sclerosis Drugs
Figure Global Production Market Share of Multiple Sclerosis Drugs by Type in 2016
Figure Oral Picture
Table Major Manufacturers of Oral
Figure Injectable Picture
Table Major Manufacturers of Injectable
Figure Intravenous Picture
Table Major Manufacturers of Intravenous
Table Applications of Multiple Sclerosis Drugs
Figure Global Consumption Volume Market Share of Multiple Sclerosis Drugs by Application in 2016
Figure Hospital Pharmacy Examples
Table Major Consumers in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Major Consumers in Retail Pharmacy
Figure Online Pharmacy Examples
Table Major Consumers in Online Pharmacy
Figure Market Share of Multiple Sclerosis Drugs by Regions
Figure North America Multiple Sclerosis Drugs Market Size (Million USD) (2012-2022)
Figure China Multiple Sclerosis Drugs Market Size (Million USD) (2012-2022)
Figure Europe Multiple Sclerosis Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Multiple Sclerosis Drugs Market Size (Million USD) (2012-2022)
Figure Japan Multiple Sclerosis Drugs Market Size (Million USD) (2012-2022)
Figure India Multiple Sclerosis Drugs Market Size (Million USD) (2012-2022)
Table Multiple Sclerosis Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Multiple Sclerosis Drugs in 2016
Figure Manufacturing Process Analysis of Multiple Sclerosis Drugs
Figure Industry Chain Structure of Multiple Sclerosis Drugs
Table Capacity and Commercial Production Date of Global Multiple Sclerosis Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Multiple Sclerosis Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Multiple Sclerosis Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Multiple Sclerosis Drugs Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Multiple Sclerosis Drugs 2012-2017
Figure Global 2012-2017E Multiple Sclerosis Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Multiple Sclerosis Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Multiple Sclerosis Drugs Capacity and Growth Rate
Table 2016 Global Multiple Sclerosis Drugs Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Multiple Sclerosis Drugs Sales (K Units) and Growth Rate
Table 2016 Global Multiple Sclerosis Drugs Sales (K Units) List (Company Segment)
Table 2012-2017E Global Multiple Sclerosis Drugs Sales Price (USD/Unit)
Table 2016 Global Multiple Sclerosis Drugs Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Multiple Sclerosis Drugs 2012-2017E
Figure North America 2012-2017E Multiple Sclerosis Drugs Sales Price (USD/Unit)
Figure North America 2016 Multiple Sclerosis Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Multiple Sclerosis Drugs 2012-2017E
Figure China 2012-2017E Multiple Sclerosis Drugs Sales Price (USD/Unit)
Figure China 2016 Multiple Sclerosis Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Multiple Sclerosis Drugs 2012-2017E
Figure Europe 2012-2017E Multiple Sclerosis Drugs Sales Price (USD/Unit)
Figure Europe 2016 Multiple Sclerosis Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Multiple Sclerosis Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Multiple Sclerosis Drugs Sales Price (USD/Unit)
Figure Southeast Asia 2016 Multiple Sclerosis Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Multiple Sclerosis Drugs 2012-2017E
Figure Japan 2012-2017E Multiple Sclerosis Drugs Sales Price (USD/Unit)
Figure Japan 2016 Multiple Sclerosis Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Multiple Sclerosis Drugs 2012-2017E
Figure India 2012-2017E Multiple Sclerosis Drugs Sales Price (USD/Unit)
Figure India 2016 Multiple Sclerosis Drugs Sales Market Share
Table Global 2012-2017E Multiple Sclerosis Drugs Sales (K Units) by Type
Table Different Types Multiple Sclerosis Drugs Product Interview Price
Table Global 2012-2017E Multiple Sclerosis Drugs Sales (K Units) by Application
Table Different Application Multiple Sclerosis Drugs Product Interview Price
Table Biogen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Biogen Multiple Sclerosis Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Biogen Multiple Sclerosis Drugs Business Region Distribution
Table Teva Pharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2016 Teva Pharmaceutical Multiple Sclerosis Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Teva Pharmaceutical Multiple Sclerosis Drugs Business Region Distribution
Table Merck KGaA Information List
Table Product A Overview
Table Product B Overview
Table 2015 Merck KGaA Multiple Sclerosis Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merck KGaA Multiple Sclerosis Drugs Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Multiple Sclerosis Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis Multiple Sclerosis Drugs Business Region Distribution
Table Bayer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bayer Multiple Sclerosis Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Bayer Multiple Sclerosis Drugs Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Multiple Sclerosis Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sanofi Multiple Sclerosis Drugs Business Region Distribution
Table Acorda Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2016 Acorda Therapeutics Multiple Sclerosis Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Acorda Therapeutics Multiple Sclerosis Drugs Business Region Distribution
Table Questcor Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Questcor Pharmaceuticals Multiple Sclerosis Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Questcor Pharmaceuticals Multiple Sclerosis Drugs Business Region Distribution
Figure Global 2017-2022 Multiple Sclerosis Drugs Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Multiple Sclerosis Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Multiple Sclerosis Drugs Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Multiple Sclerosis Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Multiple Sclerosis Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Multiple Sclerosis Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Multiple Sclerosis Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Multiple Sclerosis Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Multiple Sclerosis Drugs Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Multiple Sclerosis Drugs by Type 2017-2022
Table Global Consumption Volume (K Units) of Multiple Sclerosis Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Multiple Sclerosis Drugs by Region
  • Multiple Sclerosis - Pipeline Review, H2 2017
    Published: 21-Dec-2017        Price: US 2500 Onwards        Pages: 780
    Multiple Sclerosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis - Pipeline Review, H2 2017, provides an overview of the Multiple Sclerosis (Central Nervous System) pipeline landscape. Multiple sclerosis (MS) is a potentially debilitating disease in which body's immune system eats away at the protective sheath (myelin) that covers nerves. Damage to myelin causes ......
  • Multiple Sclerosis -Epidemiology Forecast to 2025
    Published: 01-Nov-2017        Price: US 2750 Onwards        Pages: 40
    DelveInsight "Multiple Sclerosis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Multiple Sclerosis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Multiple Sclerosis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated w......
  • Multiple Sclerosis - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Multiple Sclerosis - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Multiple Sclerosis - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patt......
  • Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 1500 Onwards        Pages: 40
    DelveInsight's, Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Relapsing Multiple Sclerosis (RMS). The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies......
  • EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2026
    Published: 01-Nov-2017        Price: US 3995 Onwards        Pages: 35
    EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2026 Summary Multiple sclerosis (MS) is an autoimmune disease affecting principally the central nervous system that causes nerve sheath demyelination followed by axon damage and paralysis. MS symptoms include muscle weakness, weak reflexes, tremor, muscle spasm, prolonged double vision, slurred speech, and balance problems. It can occur at any age, but commonly affects people of ages 15-60 years. Women are ab......
  • Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2000 Onwards        Pages: 60
    DelveInsight's, Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Secondary Progressive Multiple Sclerosis (SPMS). The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the em......
  • Global Multiple Sclerosis Partnering 2010 to 2017
    Published: 01-Nov-2017        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Multiple Sclerosis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides ......
  • Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Primary Progressive Multiple Sclerosis (PPMS)-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Primary Progressive Multiple Sclerosis (PPMS). The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Primary Progressive Multiple Sclerosis (PPMS) by development stage, therapy ty......
  • Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Relapsing Multiple Sclerosis (RMS). The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Relapsing Multiple Sclerosis (RMS) by development stage, therapy type, route of administration and m......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs